Hydrofarm raises $8.3 million gross in share and warrant sale; lender deal terms also filed
Hydrofarm sold about 8.6 million common shares and pre-funded warrants at $0.905 per share in a registered direct and private placement, with gross proceeds of $8.3 million before fees and expenses. Investors also received common warrants for up to 9,210,975 shares at $0.78, which dilutes existing holders and adds potential future share issuance. The filing also describes side letter and registration terms with lenders tied to a restructuring, including rights to designate board members subject to stockholder approval.
Key points
- Registered direct offering of 1,599,400 shares at $0.905 per share, plus a concurrent private placement of 6,971,575 shares and pre-funded warrants for 640,000 shares, all closed October 27, 2026.
- Common warrants for up to 9,210,975 shares at $0.78 per share expire 5.5 years after issue; the placement agent, ThinkEquity LLC, receives a cash fee of 8% of the purchase price.
- Under a side letter with lenders, the lenders may designate 1 initial director and up to 3 additional directors, subject to stockholder approval under Nasdaq Rule 5635.
- The company must file a resale registration statement by the 15th calendar day after the registration rights agreement date, or pay partial liquidated damages of 2.0% of the subscription amount for each affected holder.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.